ArticleJournal of breast cancer2017

MicroRNA-222 Expression as a Predictive Marker for Tumor Progression in Hormone Receptor-Positive Breast Cancer.

Song-Hee Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.